358570.KQ KOE
GI Innovation, Inc.
1W: -0.6%
1M: +11.8%
3M: -11.6%
YTD: -39.1%
1Y: -53.1%
3Y: -2.2%
₩8,820.00 ($6.51)
-720.00 (-7.55%)
Weekly Expected Move ±15.0%
₩6167
₩7493
₩8820
₩10147
₩11473
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#19
of 44
Biotechnology
Technical Signal Map
4 Bullish
0 Neutral
9 Bearish
358570.KQ
$566B
GI Innovation, Inc.
BULLISH
+50
226950.KQ
$2.4T
OliX Pharmaceuticals,Inc
BULLISH
+68
0126Z0.KS
$9.3T
Samsung Epis Holdings
BULLISH
+55
028300.KQ
$5.4T
HLB Co., Ltd.
BULLISH
+50
302440.KS
$2.9T
SK bioscience Co.,Ltd.
LEAN BEAR
-26
068270.KS
$42.1T
Celltrion, Inc.
BEARISH
-30
310210.KQ
$2.8T
Voronoi, Inc.
BEARISH
-33
196170.KQ
$18.4T
Alteogen Inc.
BEARISH
-58
207940.KS
$66.1T
Samsung Biologics Co.,Ltd.
BEARISH
-66
326030.KS
$6.0T
SK Biopharmaceuticals Co., Ltd.
BEARISH
-91
087010.KQ
$3.3T
Peptron, Inc.
BEARISH
-91
141080.KQ
$3.1T
LigaChem Biosciences Inc.
BEARISH
-91
298380.KQ
$3.0T
ABL Bio Inc.
BEARISH
-91
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 358570.KQ GI Innovation, Inc. | $566B | -14.4 | -36.2 | -60.5 | — | 1526.8 | 5 | BULLISH | -53.1 |
| 226950.KQ OliX Pharmaceuticals,Inc | $2.4T | -193.6 | -10.8 | -75.7 | -418.6 | 80.9 | 3 | BULLISH | 124.2 |
| 0126Z0.KS Samsung Epis Holdings | $9.3T | — | — | — | — | — | — | BULLISH | — |
| 028300.KQ HLB Co., Ltd. | $5.4T | -25.0 | -54.4 | -12.6 | -274.8 | 29.0 | 3 | BULLISH | -5.0 |
| 302440.KS SK bioscience Co.,Ltd. | $2.9T | -34.2 | -4.5 | -8.5 | -9.0 | 23.2 | 4 | LEAN BEAR | -19.7 |
| 068270.KS Celltrion, Inc. | $42.1T | 26.4 | 9.2 | 6.6 | 26.6 | 30.6 | 5 | BEARISH | 4.9 |
| 310210.KQ Voronoi, Inc. | $2.8T | -35.4 | -128.6 | -193.4 | — | 24.2 | 2 | BEARISH | 21.5 |
| 196170.KQ Alteogen Inc. | $18.4T | 82.4 | 43.5 | 56.4 | 41.2 | 60.7 | 6 | BEARISH | -39.6 |
| 207940.KS Samsung Biologics Co.,Ltd. | $66.1T | 31.6 | 19.9 | 20.0 | 32.6 | -9.6 | 7 | BEARISH | -13.8 |
| 326030.KS SK Biopharmaceuticals Co., Ltd. | $6.0T | 15.3 | 49.6 | 59.7 | 34.4 | 38.9 | 7 | BEARISH | -23.9 |
| 087010.KQ Peptron, Inc. | $3.3T | -146.7 | -15.0 | -23.7 | -533.7 | 15.9 | 2 | BEARISH | -57.0 |
| 141080.KQ LigaChem Biosciences Inc. | $3.1T | -15.4 | -36.8 | -771.9 | -1286.9 | -33.4 | 1 | BEARISH | -45.0 |
| 298380.KQ ABL Bio Inc. | $3.0T | -35.6 | -44.3 | -113.7 | -74.7 | -63.9 | 1 | BEARISH | -31.0 |
| 358570.KQ GI Innovation, Inc. | $566B | -14.4 | -36.2 | -60.5 | — | 1526.8 | 5 | BULLISH | -53.1 |
| 226950.KQ OliX Pharmaceuticals,Inc | $2.4T | -193.6 | -10.8 | -75.7 | -418.6 | 80.9 | 3 | BULLISH | 124.2 |
| 0126Z0.KS Samsung Epis Holdings | $9.3T | — | — | — | — | — | — | BULLISH | — |
| 028300.KQ HLB Co., Ltd. | $5.4T | -25.0 | -54.4 | -12.6 | -274.8 | 29.0 | 3 | BULLISH | -5.0 |
| 302440.KS SK bioscience Co.,Ltd. | $2.9T | -34.2 | -4.5 | -8.5 | -9.0 | 23.2 | 4 | LEAN BEAR | -19.7 |
| 068270.KS Celltrion, Inc. | $42.1T | 26.4 | 9.2 | 6.6 | 26.6 | 30.6 | 5 | BEARISH | 4.9 |
| 310210.KQ Voronoi, Inc. | $2.8T | -35.4 | -128.6 | -193.4 | — | 24.2 | 2 | BEARISH | 21.5 |
| 196170.KQ Alteogen Inc. | $18.4T | 82.4 | 43.5 | 56.4 | 41.2 | 60.7 | 6 | BEARISH | -39.6 |
| 207940.KS Samsung Biologics Co.,Ltd. | $66.1T | 31.6 | 19.9 | 20.0 | 32.6 | -9.6 | 7 | BEARISH | -13.8 |
| 326030.KS SK Biopharmaceuticals Co., Ltd. | $6.0T | 15.3 | 49.6 | 59.7 | 34.4 | 38.9 | 7 | BEARISH | -23.9 |
| 087010.KQ Peptron, Inc. | $3.3T | -146.7 | -15.0 | -23.7 | -533.7 | 15.9 | 2 | BEARISH | -57.0 |
| 141080.KQ LigaChem Biosciences Inc. | $3.1T | -15.4 | -36.8 | -771.9 | -1286.9 | -33.4 | 1 | BEARISH | -45.0 |
| 298380.KQ ABL Bio Inc. | $3.0T | -35.6 | -44.3 | -113.7 | -74.7 | -63.9 | 1 | BEARISH | -31.0 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
358570.KQ vs Benchmarks
ROIC
Revenue Growth
P/E Ratio
ROE
Piotroski F